Roslin Biomed (A)
Subject
Strategy and Entrepreneurship, Strategy and Entrepreneurship
Authors / Editors
Tansley R; Birkinshaw J; Murray G
Biographies
Publication Year
2002
Abstract
This case focuses on the formation of Roslin Biomed, a spin-off from the Roslin Institute that was formed to commercialise the nuclear transfer technology behind the successful cloning of Dolly the sheep. The case describes the background to the birth of Dolly and then follows the subsequent events - The establishment of Roslin Biomed, the recruitment of Simon Best as Chief Executive of the company and his discussions with various partner companies.
Topic List
Technology Transfer, Knowledge Management, Acquistition
Industry
Biotech
Publication Event Date
1999
LBS Case Number
CS-02-005
Location
Edinburgh
Publication Organisation Size
Small - Medium
Project Funder
Fondation Banque De France
Publication Research Centre
Institute of Finance and Accounting
Available on ECCH
No
